IFNG and neoplasm: Cytokines (e.g., interferon gamma (IFN-γ) and ILs) are commonly used in cancer immunotherapy due to their wide range of anti-tumor activity, such as stimulating immune effector cells, increasing tumor cell recognition and activating cytotoxic cells [70,77].